Altaner, Cestmir <br/><br/>
Prodrug cancer gene therapy.  [electronic resource] 

 -  Cancer letters  Nov 2008 
 - 191-201 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2008.04.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--metabolism<br/>Cytochrome P-450 Enzyme System--genetics<br/>Cytosine Deaminase--genetics<br/>Enzymes--genetics<br/>Flucytosine--therapeutic use<br/>Ganciclovir--therapeutic use<br/>Gene Transfer Techniques<br/>Genetic Therapy--methods<br/>Genetic Vectors<br/>Humans<br/>Mesenchymal Stem Cell Transplantation<br/>Mesenchymal Stem Cells--enzymology<br/>Neoplasms--drug therapy<br/>Prodrugs--metabolism<br/>Thymidine Kinase--genetics